ClinicalTrials.Veeva

Find clinical trials for Ovarian Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Epithelial Carcinoma
Cancer
Carcinoma
Endometrial Cancer
Fallopian Tube Cancer
Breast Cancer
Triple Negative Breast Cancer

Ovarian Cancer trials near Berlin, BE, DEU:

MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

of Estrogen-receptor (ER) positive high and low grade epithelial ovarian cancer (including fallopian tube and primary peritoneal ca...

Enrolling
High-grade Serous Ovarian Carcinoma (HGSOC)
Ovarian Neoplasm Epithelial
Drug: Letrozole 2.5mg
Other: Placebo

Phase 3

Swiss GO Trial Group

Berlin, Germany and 42 other locations

high grade endometrioid (based on local histopathological findings) ovarian cancer, fallopian tube cancer, primary periton...

Active, not recruiting
Primary Peritoneal Cancer
Fallopian Tube Cancer
Drug: Rucaparib
Drug: Placebos

Phase 3

North Eastern German Society of Gynaecological Oncology

Berlin, Germany and 18 other locations

followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...

Active, not recruiting
Advanced Ovarian Cancer
Drug: Durvalumab placebo
Drug: Bevacizumab

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 213 other locations

of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...

Active, not recruiting
Relapsed Ovarian Cancer
Following Complete or Partial Response to Platinum Based Chemotherapy
Drug: Olaparib 300mg tablets
Drug: Placebo to match olaparib 300mg

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 125 other locations

patients will have tissue based diagnosis of advanced/recurrent ovarian cancer (clear cell, endometrioid or high grade serous or ca...

Active, not recruiting
Ovarian Neoplasms
Ovarian Clear Cell Adenocarcinoma
Drug: TAK228
Drug: Paclitaxel

Phase 2

Imperial College London
Imperial College London

Berlin, Germany and 14 other locations

of alpelisib and olaparib compared with single agent cytotoxic chemotherapy in patients with platinum resistant or refractory high-grade serous ovarian...

Active, not recruiting
Ovarian Cancer
Drug: Pegylated liposomal doxorubicin (PLD)
Drug: Olaparib

Phase 3

Novartis
Novartis

Berlin, Germany and 93 other locations

to chemotherapy and in maintenance, in patients with low grade ovarian cancer (including patients with primary peritoneal and / or...

Enrolling
Fallopian Tube Cancer
Ovarian Cancer
Drug: Pembrolizumab

Phase 2

North Eastern German Society of Gynaecological Oncology

Berlin, Germany and 1 other location

chemotherapy and in maintenance, in patients presenting epithelial ovarian cancer (including patients with primary peritoneal and /...

Active, not recruiting
Ovarian Cancer
Drug: placebo + avastin + platinum-based chemotherapy
Drug: atezolizumab + avastin + platinum-based chemotherapy

Phase 3

ARCAGY/ GINECO GROUP

Berlin, Germany and 74 other locations

This is a multi-center, prospective, open-label, phase II trial. Patients with suspected advanced ovarian cancer planned to undergo...

Enrolling
Epithelial Ovarian Cancer
Drug: olaparib
Drug: durvalumab

Phase 2

AGO Research

Berlin, Germany and 4 other locations

in combination with pembrolizumab versus protocol-specific Investigator's choice chemotherapy in patients with platinum-resistant epithelial ovarian...

Active, not recruiting
Primary Peritoneal Cancer
Fallopian Tube Cancer
Biological: Pembrolizumab
Biological: Nemvaleukin

Phase 3

Mural Oncology, Inc

Berlin, Germany and 90 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems